Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary

Medical Principles and Practice

Volumn 14, Issue 3, 2005, Pages 155-160

  Freudenberg, Lutz S ^a   Fischer, Markus ^a   Antoch, Gerald ^a   Jentzen, Walter ^a   Gutzeit, Andreas ^a   Rosenbaum, Sandra J ^a   Bockisch, Andreas ^a   Egelhof, Thomas ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Dual modality; Fluorodeoxyglucose; Positron emission tomography computed tomography; Unknown primary tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; HEAD AND NECK TUMOR; METASTASIS; MIDDLE AGED; NEOPLASM; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 18644386584     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084632     Document Type: Article

References (39)

1. Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P: Unknown primary carcinoma: Natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994;12:1272-1280.
2. Muir C: Cancer of unknown primary site. Cancer 1995;75:353-356.
3. van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, Hillen HF: Epidemiology of unknown primary tumours: Incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 2002;38:409-413.
4. Stoeckli SJ, Mosna-Firlejczyk K, Goerres GW: Lymph node metastasis of squamous cell carcinoma from an unknown primary: Impact of positron emission tomography. Eur J Nucl Med 2003;30:411-416.
5. De Braud F, Heilbrun LK, Ahmed K, Sakr W, Ensley JF, Kish JA, Tapazoglou E, al-Sarraf M: Metastatic squamous cell carcinoma of an unknown primary localized to the neck. Cancer 1989;6:510-515.
6. Glynne Jones RGT, Anand A, Young TE, Berry RJ: Metastatic carcinoma in the cervical lymph nodes from an occult primary: A conservative approach to the role of radiotherapy. Int J Radiat Oncol 1990;18:289-294.
7. Marcial-Vega VA, Cardenes H, Perez CA, Devineni VR, Simpson JR, Fredrickson JM, Sessions DG, Spector GG, Thawley SE: Cervical metastases from unknown primaries: Radiotherapy management and appearance of subsequent primaries. Int J Radiat Oncol Biol Phys 1990;19:919-928.
8. Nieder C, Gregoire V, Ang KK: Cervical lymph node metastasis from occult squamous cell carcinoma: Cut down a tree to get an apple? Int J Radiat Oncol Biol Phys 2001;50:727-733.
9. Nordstrom DG, Tewfik HH, Latourette HB: Cervical lymph node metastases from an unknown primary. Radiat Oncol Biol Phys 1979; 5:73-76.
10. Leipzig B, Winter ML, Hokanson JA: Cervical node metastases of unknown origin. Laryngoscope 1981;91:593-598.
11. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME: A tabulated summary of the FDG PET literature. J Nucl Med 2001;42(suppl 5):1S-93S.
12. Mantaka P, Baum RP, Hertel A, Adams S, Niessen A, Sengupta S, Hor G: PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): Influence on patients' diagnostic and therapeutic management. Cancer Biother Radiopharm 2003;18:47-58.
13. Reske SN, Kotzerke J: FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, 'Onko-PET III', 21 July and 19 September 2000. Eur J Nucl Med 2001;28:1707-1723.
14. Delgado-Bolton RC, Fernandez-Perez C, Gonzalez-Mate A, Carreras JL: Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med 2003;44:1301-1314.
15. Charron M, Beyer T, Bohnen NN, Kinahan PE, Dachille M, Jerin J, Nutt R, Meltzer CC, Villemagne V, Townsend DW: Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 2000;25:905-910.
16. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R: A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-1379.
17. Townsend DW, Cherry SR: Combined anatomy and function: The path of true image fusion. Eur Radiol 2001;11:1968-1974.
18. Beyer T, Townsend DW, Blodgett TM: Dual-modality PET/CT tomography for clinical oncology. Q J Nucl Med 2002;46:24-34.
19. Goerres GW, Hany TF, Kamel E, von Schulthess GK, Buck A: Head and neck imaging with PET and PET/CT: Artefacts from dental metallic implants. Eur J Nucl Med 2002;29: 367-370.
20. Antoch G, Freudenberg LS, Egelhof T, Stattaus J, Jentzen W, Debatin JF, Bockisch A: Focal tracer uptake: A potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 2002;43:1339-1342.
21. Beyer T, Antoch G, Blodgett T, Freudenberg LS, Akhurst T, Mueller S: Dual-modality PET/CT imaging: The effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med 2003;30:588-596.
22. Antoch G, Freudenberg LS, Stattaus J, Jentzen W, Mueller SP, Debatin JF, Bockisch A: Whole-body positron emission tomography-CT: Optimized CT using oral and IV contrast materials. AJR Am J Roentgenol 2002;179: 1555-1560.
23. Beyer T, Antoch G, Müller S, Egelhof T, Freudenberg LS, Debatin J, Bockisch A: Protocol considerations for combined PET/CT imaging. J Nucl Med 2004;45(suppl 1):25S-35S.
24. Kinahan PE, Townsend DW, Beyer T, Sashin D: Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998;25:2046-2053.
25. Antoch G, Kuehl H, Kanja J, Lauenstein TC, Schneemann H, Hauth E, Jentzen W, Beyer T, Goehde SC, Debatin JF: Dual-modality PET/ CT scanning with negative oral contrast agent to avoid artifacts: Introduction and evaluation. Radiology 2004;230:879-885.
26. Huang SC: Anatomy of SUV. Nucl Med Biol 2000;27:643-646.
27. Strauss LG, Conti PS: The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
28. Di Martino E, Nowak B, Hassan HA, Hausmann R, Adam G, Buell U, Westhofen M: Diagnosis and staging of head and neck cancer. Arch Otolaryngol Head Neck Surg 2000;126: 1457-1461.
29. Johansen J, Eigtved A, Buchwald C, Theilgaard SA: Implication of 18-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: A Danish cohort study. Laryngoscope 2002;112:2009-2014.
30. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ: Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999; 109:880-885.
31. Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenburg JL, Vaalburg W, Vermey A: Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998;15:1160-1166.
32. Bohuslavizki KH, Klutmann S, Kröger S, Sonnemann U, Buchert R, Werner JA, Mester J, Clausen M: FDG PET detection of unknown primary tumors. J Nucl Med 2000;41:816-822.
33. Rades D, Kühnel G, Wildfang I, Börner AR, Knapp W, Karstens JH: The value of positron emission tomography (PET) in the treatment of patients with cancer of unknown primary (CUP). Strahlenther Onkol 2001;177:525-529.
34. Greven K, Keyes JW, Williams DW, Mc Guirt WF, Joyce WT: Occult primary tumors of the head and neck; Lack of benefit from positron emission tomography imaging with 2-(F-18) fluoro-2-deoxy-D-glucose. Cancer 1999;86: 114-118.
35. Schiepers C, Hoh CK: Positron emission tomography as a diagnostic tool in oncology. Eur Radiol 1998;8:1481-1494.
36. Antoch G, Kanja J, Bauer S, Kuehl H, Renzing-Koehler K, Schuette J, Bockisch A, Debatin JF, Freudenberg LS: Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 2004;45:357-365.
37. Freudenberg LS, Antoch G, Schutt P, Beyer T, Jentzen W, Muller SP, Gorges R, Nowrousian MR, Bockisch A, Debatin JF: FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med 2004;31:325-329.
38. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin JF, Freudenberg LS: Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging. Radiology 2003;229:526-533.
39. van de Wouw AJ, Jansen RLH, Speel EJM, Hillen HFP: The unknown biology of the unknown primary tumour: A literature review. Ann Oncol 2003;14:191-196. Med Princ Pract 2005;14:161-164